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Review question(s)
1. What are the direct costs of caring for the eligible population of the programs (e.g., medications, transports,
accommodation and caring)?
2. What are the indirect costs of caring for the eligible population of the programs (e.g., opportunity cost of family
carers, cost of alternative programs)?
3. What are the outcomes of national health/disability insurance programs to their target population (i.e., QALY,
DALY, labour force participation)?
4. What is the increment cost-effectiveness ratio of these programs?
5. Are these programs cost-effective in caring for their eligible population?
6. What are additional effects (e.g., employment, income) of the programs to the target population?
7. What are the spillover effects of the programs to non-eligible population (e.g., employment and income of family
carers, prices of health/disability cares, number of service providers)?
Searches
We plan to search the following databases: PubMed, Scopus, EMBASE, EconLit, RePEc, Web of Science, CINAHL,
Campbell Collaboration Library of Systematic Reviews, Cochrane Library, DARE, NHS EED, HTA, HEED and
EPPI Centre's Database of promoting health effectiveness reviews (DoPHER) and Bibliomap. 
The search strategy will vary depending on the functionality of the databases, but in general will be; (cost benefit*
OR cost effectiveness OR economic*) AND (disability insurance OR national health OR health insurance). Test runs
of this search have found huge result sets and so using the NOT function e.g. NOT (drug* or obesity or diabetes or
cancer or heart or wound* or disease or illness) will be used to refine the search. The searches will be run in Title and
Abstract fields and limited to the English language.
Types of study to be included
We plan to include the following type of studies: 
Cost effectiveness/utility/benefit analysis of the programs; and
Econometric assessment of programs' effects.
Condition or domain being studied
The conditions in this review are covered in the eligibility of the national health/disability insurance programs. In
particular, national health insurance programs include almost all health conditions whilst national disability insurance
programs cover majority of needs for permanent disability care. Thus, we do not set pre-determined conditions in this
review.
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Participants/ population
Participants of the review include those covered by national health/disability insurance programs. Often, these
programs cover the whole population but recipients of health/disability care services should meet eligibility criteria.
Thus, this review covers the whole population of countries with a national health/disability insurance program.
Intervention(s), exposure(s)
The main intervention is the introduction/expansion/changes in national health/disability insurance programs. These
programs are often designed to protect people with illness/disability from catastrophic payment as a result of illness
or disability status. For example, the interventions of national health insurance programs provide no out-of-pocket for
GP visit and discounted medications; national disability insurance programs provide packaged payment for disability
care services such as medications, transport and accommodation for people with a permanent disability.
Comparator(s)/ control
The comparators include eligible people without access to national health/disability insurance (for example, before
the introduction of new programs or the extension of existing programs; or populations ineligible for these programs).
Context
We aim to compare studies that examine the cost-effectiveness of providing tax-funded national insurance for
disability and health care. The null scenario includes the case where the population depends on private insurance or
no insurance at all. We include analysis at macro-level: state, country or regions. We exclude studies at individual
levels or of specific conditions because it will be difficult to aggregate across individuals and conditions to achieve an
estimation of cost-effectiveness of the whole programs.
Outcome(s)
Primary outcomes
1) Quality adjusted life year or disability adjusted life year or life year of programs’ beneficiaries (e.g., people with
disability or those eligible for national health insurance scheme);
2) Income that beneficiaries received from the programs;
3) Labour force participation (e.g., employment status, working hours per week);
4) Time spend off work as a result of injuries/temporary disability;
5) Costs of treatments/care/rehabilitation.
Secondary outcomes
Secondary outcomes include additional effects to beneficiary such as income and employment. We also plan to
measure spill-over effects of national health/insurance programs to non-eligible population via changes in
health/disability care markets such as number of services providers, prices, quality of services, income and
employment of home carers.
Data extraction, (selection and coding)
Studies are filtered to have a subset studies should have the following characteristics: contain cost effectiveness and
health/disability insurance in the title. The final list of studies will be selected after reading abstracts and full text. 
The data to be extracted include: 
1) Year, country of study (so that money value will be adjusted for variations in inflation and purchasing power over
time and across countries);
2) Costs of providing health/disability (e.g., costs to the programs and to recipients);
3) Benefits of the programs to recipients (e.g., quality adjusted life year gains);
4) Incremental cost-effectiveness ratio;
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5) Other benefits (income, employment) to beneficiaries and family carers;
6) Changes in the health/disability care markets (prices, number of providers).
The data will include mean and confidence intervals of the estimates when applicable.
Risk of bias (quality) assessment
Studies may apply different methods in cost-effectiveness analysis, and hence aggregation of results is difficult. We
plan to mitigate this issue by grouping studies that use similar methods, adjust money measures to inflation and
purchasing power across countries.
Strategy for data synthesis
Reference data are managed by Endnote to compile record of studies, remove duplication and set filter to select
subset of reference (exclusion/inclusion). Data are extracted and entered manually to Excel spreadsheets using a
template.
The analysis of data will be conducted using the “metaphor” package in R. Since we restrict the review at macro-level
studies, the data use will be at aggregate level. The synthesis of data also restricts to quantitative data. In particular,
we will synthesis means, confidence intervals for outcomes of interests across studies such as incremental cost-
effectiveness ratios, income and employment (e.g., work hours per week).
Analysis of subgroups or subsets
None planned
Dissemination plans
We plan to disseminate the results of this study via various channels to reach relevant target audiences. Firstly, an
academic audience will be reached widely by publishing the research to a peer-review journal. To increase the reach
of the research we plan to publish the research in prestige open-access journals such as PLOS ONE. Secondly, we
will disseminate the research outcomes to policymakers by presenting the research at conferences on disability
insurance and/or health care services delivery. Finally, we will reach the general public via the provision of an easy-
English version of the paper to media outlets and the blog of Australian Health Service Innovation – the home of the
research team.
Contact details for further information
Dr Nghiem
Institute of Health and Biomedical Innovation. 
60 Musk Avenue, Kelvin Grove, QLD 4059 
Australia
son.nghiem@qut.edu.au
Organisational affiliation of the review
Australian Centre for Health Services Innovation (AusHSI), Institute of Health and Biomedical Innovation (IHBI),
Queensland University of Technology (QUT). 60 Musk Avenue, Kelvin Grove, QLD 4059 Australia
http://www.aushsi.org.au/
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Anticipated or actual start date
29 May 2015
Anticipated completion date
01 June 2016
Funding sources/sponsors
There is no funding for this research at the time of writing
Conflicts of interest
None known
Other registration details
This review has not been registered previously.
Language
English
Country
Australia
Subject index terms status
Subject indexing assigned by CRD
Subject index terms
Cost-Benefit Analysis; Developed Countries; Disabled Persons; Humans; Insurance, Disability; National Health
Programs
Any other information
The review team consists of diverse disciplines: a health economist, a statistician, an econometrician, and a librarian.
Stage of review
Ongoing
Date of registration in PROSPERO
27 April 2015
Date of publication of this revision
27 April 2015
DOI
10.15124/CRD42015019897
Stage of review at time of this submission Started Completed
Preliminary searches No   No 
Piloting of the study selection process   No   No 
Formal screening of search results against eligibility criteria   No   No 
Data extraction   No   No 
Risk of bias (quality) assessment   No   No 
Data analysis   No   No 
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